Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.

Segura SE, Hoang L, Boros M, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park KJ, Soslow RA, Stolnicu S.

Int J Gynecol Pathol. 2019 Sep 11. doi: 10.1097/PGP.0000000000000633. [Epub ahead of print]

PMID:
31517653
2.

Intra- and Interspecies Variability of Single-Cell Innate Fluorescence Signature of Microbial Cell.

Yawata Y, Kiyokawa T, Kawamura Y, Hirayama T, Takabe K, Nomura N.

Appl Environ Microbiol. 2019 Aug 29;85(18). pii: e00608-19. doi: 10.1128/AEM.00608-19. Print 2019 Sep 15.

3.

Additional validation of Osaka method (0.01 mol/L dithiothreitol) for negating the daratumumab interference.

Hosokawa M, Kashiwagi H, Nakayama K, Sakuragi M, Nakao M, Morikawa T, Kiyokawa T, Aochi H, Nagamine K, Shibayama H, Tomiyama Y.

Transfusion. 2019 Jul;59(7):2479-2480. doi: 10.1111/trf.15305. No abstract available.

PMID:
31268593
4.

Glucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Clin Rheumatol. 2019 Jun 7. doi: 10.1007/s10067-019-04633-y. [Epub ahead of print]

PMID:
31175481
5.

High plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritis.

Kiyokawa T, Hanaoka H, Iida H, Ishimori K, Takakuwa Y, Okazaki T, Ozaki S, Kawahata K.

Mod Rheumatol. 2019 Jun 13:1-8. doi: 10.1080/14397595.2019.1623435. [Epub ahead of print]

PMID:
31135249
6.

Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype.

Takenaka M, Köbel M, Garsed DW, Fereday S, Pandey A, Etemadmoghadam D, Hendley J, Kawabata A, Noguchi D, Yanaihara N, Takahashi H, Kiyokawa T, Ikegami M, Takano H, Isonishi S, Ochiai K, Traficante N, Gadipally S, Semple T, Vassiliadis D, Amarasinghe K, Li J, Mir Arnau G, Okamoto A, Friedlander M, Bowtell DDL; Australian Ovarian Cancer Study Group.

Clin Cancer Res. 2019 Jul 1;25(13):3962-3973. doi: 10.1158/1078-0432.CCR-18-3691. Epub 2019 Apr 9.

PMID:
30967419
7.

Recent trends from the results of clinical trials on gastric cancer surgery.

Kiyokawa T, Fukagawa T.

Cancer Commun (Lond). 2019 Mar 27;39(1):11. doi: 10.1186/s40880-019-0360-1. Review.

8.

Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse.

Takakuwa Y, Hanaoka H, Kiyokawa T, Iida H, Ishimori K, Uekusa T, Yamada H, Kawahata K.

Clin Exp Rheumatol. 2019 Feb 11. [Epub ahead of print]

PMID:
30767871
9.

A low perfusion-metabolic mismatch in 99m Tl and 123 I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvement.

Iida H, Hanaoka H, Okada Y, Kiyokawa T, Takakuwa Y, Yamada H, Okazaki T, Ozaki S, Yamaguchi K, Nakajima Y, Kawahata K.

Int J Rheum Dis. 2019 Jun;22(6):1008-1015. doi: 10.1111/1756-185X.13508. Epub 2019 Feb 6.

PMID:
30729690
10.

Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).

Stolnicu S, Hoang L, Chiu D, Hanko-Bauer O, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park KJ, Abu-Rustum NR, Soslow RA.

Am J Surg Pathol. 2019 Apr;43(4):466-474. doi: 10.1097/PAS.0000000000001224.

PMID:
30720532
11.

Low-dose rituximab as induction therapy for ANCA-associated vasculitis.

Takakuwa Y, Hanaoka H, Kiyokawa T, Iida H, Fujimoto H, Yamasaki Y, Yamada H, Kawahata K.

Clin Rheumatol. 2019 Apr;38(4):1217-1223. doi: 10.1007/s10067-019-04443-2. Epub 2019 Jan 25.

PMID:
30680533
12.

Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Intern Med. 2019 May 1;58(9):1257-1262. doi: 10.2169/internalmedicine.1999-18. Epub 2019 Jan 10.

13.

Low additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitor.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Int J Rheum Dis. 2019 Mar;22(3):468-472. doi: 10.1111/1756-185X.13418. Epub 2018 Nov 8.

PMID:
30406967
14.

A positive direct Coombs' test in the absence of hemolytic anemia predicts high disease activity and poor renal response in systemic lupus erythematosus.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Lupus. 2018 Dec;27(14):2274-2278. doi: 10.1177/0961203318809182. Epub 2018 Oct 25.

PMID:
30354857
15.

Distinct effects of daratumumab on indirect and direct antiglobulin tests: a new method employing 0.01 mol/L dithiothreitol for negating the daratumumab interference with preserving K antigenicity (Osaka method).

Hosokawa M, Kashiwagi H, Nakayama K, Sakuragi M, Nakao M, Morikawa T, Kiyokawa T, Aochi H, Nagamine K, Shibayama H, Tomiyama Y.

Transfusion. 2018 Dec;58(12):3003-3013. doi: 10.1111/trf.14900. Epub 2018 Sep 28.

PMID:
30267414
16.

Cervical adenosquamous carcinoma: detailed analysis of morphology, immunohistochemical profile, and clinical outcomes in 59 cases.

Stolnicu S, Hoang L, Hanko-Bauer O, Barsan I, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park KJ, Soslow RA.

Mod Pathol. 2019 Feb;32(2):269-279. doi: 10.1038/s41379-018-0123-6. Epub 2018 Sep 26.

17.

Gastric-type Adenocarcinoma of the Cervix: Tumor With Wide Range of Histologic Appearances.

Pirog EC, Park KJ, Kiyokawa T, Zhang X, Chen W, Jenkins D, Quint W.

Adv Anat Pathol. 2019 Jan;26(1):1-12. doi: 10.1097/PAP.0000000000000216. Review.

PMID:
30234500
18.

Mycophenolate mofetil treatment with or without a calcineurin inhibitor in resistant inflammatory myopathy.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Clin Rheumatol. 2019 Feb;38(2):585-590. doi: 10.1007/s10067-018-4294-9. Epub 2018 Sep 14.

PMID:
30218287
19.

Uterine PEComas: A Morphologic, Immunohistochemical, and Molecular Analysis of 32 Tumors.

Bennett JA, Braga AC, Pinto A, Van de Vijver K, Cornejo K, Pesci A, Zhang L, Morales-Oyarvide V, Kiyokawa T, Zannoni GF, Carlson J, Slavik T, Tornos C, Antonescu CR, Oliva E.

Am J Surg Pathol. 2018 Oct;42(10):1370-1383. doi: 10.1097/PAS.0000000000001119.

PMID:
30001237
20.

Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Oliva E, Park KJ, Abu-Rustum NR, Pike MC, Soslow RA.

Gynecol Oncol. 2018 Jul;150(1):56-60. doi: 10.1016/j.ygyno.2018.04.570. Epub 2018 May 30.

21.

Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.

Stolnicu S, Barsan I, Hoang L, Patel P, Chiriboga L, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.

Am J Surg Pathol. 2018 Aug;42(8):989-1000. doi: 10.1097/PAS.0000000000001090.

22.

Exosome‑encapsulated microRNA‑23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage.

Kumata Y, Iinuma H, Suzuki Y, Tsukahara D, Midorikawa H, Igarashi Y, Soeda N, Kiyokawa T, Horikawa M, Fukushima R.

Oncol Rep. 2018 Jul;40(1):319-330. doi: 10.3892/or.2018.6418. Epub 2018 May 8.

PMID:
29749537
23.

Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Okazaki T, Yamada H, Ozaki S, Kawahata K.

PLoS One. 2018 May 3;13(5):e0196172. doi: 10.1371/journal.pone.0196172. eCollection 2018.

24.

Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV.

Hanaoka H, Iida H, Kiyokawa T, Takakuwa Y, Kawahata K.

Arthritis Res Ther. 2018 May 2;20(1):86. doi: 10.1186/s13075-018-1576-1. No abstract available.

25.

Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma.

Nishikimi K, Nakagawa K, Tate S, Matsuoka A, Iwamoto M, Kiyokawa T, Shozu M.

Am J Clin Pathol. 2018 Mar 7;149(4):352-361. doi: 10.1093/ajcp/aqx166.

PMID:
29474637
26.

Dedifferentiated endometrial carcinoma: A report of three cases and review of the literature.

Yokomizo R, Yamada K, Iida Y, Kiyokawa T, Ueda K, Saito M, Yanaihara N, Nakamura M, Okamoto A.

Mol Clin Oncol. 2017 Dec;7(6):1008-1012. doi: 10.3892/mco.2017.1437. Epub 2017 Oct 3.

27.

Chemoresistance of Gastric-Type Mucinous Carcinoma of the Uterine Cervix: A Study of the Sankai Gynecology Study Group.

Kojima A, Shimada M, Mikami Y, Nagao S, Takeshima N, Sugiyama T, Teramoto N, Kiyokawa T, Kigawa J, Nishimura R; Sankai Gynecology Study Group.

Int J Gynecol Cancer. 2018 Jan;28(1):99-106. doi: 10.1097/IGC.0000000000001145.

PMID:
29206664
28.

High-rate nitrogen removal from waste brine by marine anammox bacteria in a pilot-scale UASB reactor.

Yokota N, Watanabe Y, Tokutomi T, Kiyokawa T, Hori T, Ikeda D, Song K, Hosomi M, Terada A.

Appl Microbiol Biotechnol. 2018 Feb;102(3):1501-1512. doi: 10.1007/s00253-017-8663-0. Epub 2017 Dec 4.

PMID:
29204898
29.

MRI findings for primary fallopian tube cancer: correlation with pathological findings.

Kitai S, Kiyokawa T, Tanaka YO, Onoue K, Takahashi H, Saitou M, Okamoto A, Fukuda K.

Jpn J Radiol. 2018 Feb;36(2):134-141. doi: 10.1007/s11604-017-0705-0. Epub 2017 Nov 18.

PMID:
29151178
30.

International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E, Park KJ, Soslow RA.

Am J Surg Pathol. 2018 Feb;42(2):214-226. doi: 10.1097/PAS.0000000000000986.

31.

Immature platelet fraction (IPF) as a predictive value for thrombopoietic recovery after allogeneic stem cell transplantation.

Sakuragi M, Hayashi S, Maruyama M, Kiyokawa T, Nagamine K, Fujita J, Maeda T, Kato H, Kashiwagi H, Kanakura Y, Tomiyama Y.

Int J Hematol. 2018 Mar;107(3):320-326. doi: 10.1007/s12185-017-2344-8. Epub 2017 Oct 12.

PMID:
29027117
32.

Rhabdomyolysis in a Patient with Polyarteritis Nodosa.

Iida H, Hanaoka H, Asari Y, Ishimori K, Kiyokawa T, Takakuwa Y, Yamasaki Y, Yamada H, Okazaki T, Doi M, Ozaki S.

Intern Med. 2018 Jan 1;57(1):101-106. doi: 10.2169/internalmedicine.8913-17. Epub 2017 Oct 11.

33.

A preliminary study of effects of low-intensity pulsed ultrasound (LIPUS) irradiation on dentoalveolar ankylosis.

Kiyokawa T, Motoyoshi M, Inaba M, Sano R, Saiki A, Torigoe G, Asano M, Shimizu N.

J Oral Sci. 2017;59(3):447-451. doi: 10.2334/josnusd.16-0551.

34.

Clinical Significance of Area of Psoas Major Muscle on Computed Tomography after Gastrectomy in Gastric Cancer Patients.

Yaguchi Y, Kumata Y, Horikawa M, Kiyokawa T, Iinuma H, Inaba T, Fukushima R.

Ann Nutr Metab. 2017;71(3-4):145-149. doi: 10.1159/000480520. Epub 2017 Sep 8.

35.

Two cases of early recurrence after transabdominal preperitoneal inguinal hernia repair.

Yaguchi Y, Inaba T, Kumata Y, Horikawa M, Kiyokawa T, Fukushima R.

Asian J Endosc Surg. 2018 Feb;11(1):71-74. doi: 10.1111/ases.12408. Epub 2017 Jul 13. Review.

PMID:
28707383
36.

Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma.

Kawabata A, Yanaihara N, Nagata C, Saito M, Noguchi D, Takenaka M, Iida Y, Takano H, Yamada K, Iwamoto M, Kiyokawa T, Okamoto A.

Gynecol Oncol. 2017 Sep;146(3):609-614. doi: 10.1016/j.ygyno.2017.06.027. Epub 2017 Jun 30.

PMID:
28673661
37.

Seven esophageal perforation cases after aortic replacement/stenting for thoracic aortic dissection or aneurysm.

Yaguchi Y, Kumata Y, Horikawa M, Kiyokawa T, Inaba T, Fukushima R.

Surg Case Rep. 2017 Dec;3(1):77. doi: 10.1186/s40792-017-0354-7. Epub 2017 Jun 19.

38.

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.

Jang JYA, Yanaihara N, Pujade-Lauraine E, Mikami Y, Oda K, Bookman M, Ledermann J, Shimada M, Kiyokawa T, Kim BG, Matsumura N, Kaku T, Kuroda T, Nagayoshi Y, Kawabata A, Iida Y, Kim JW, Quinn M, Okamoto A.

J Gynecol Oncol. 2017 Jul;28(4):e54. doi: 10.3802/jgo.2017.28.e54. Review.

39.

Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.

Hanaoka H, Kiyokawa T, Iida H, Ishimori K, Takakuwa Y, Okazaki T, Yamada H, Ichikawa D, Shirai S, Koike J, Ozaki S.

PLoS One. 2017 Apr 6;12(4):e0175152. doi: 10.1371/journal.pone.0175152. eCollection 2017.

40.

A Versatile and Rapidly Deployable Device to Enable Spatiotemporal Observations of the Sessile Microbes and Environmental Surfaces.

Kiyokawa T, Usuba R, Obana N, Yokokawa M, Toyofuku M, Suzuki H, Nomura N.

Microbes Environ. 2017 Mar 31;32(1):88-91. doi: 10.1264/jsme2.ME16161. Epub 2017 Mar 17.

41.

A case of ovarian steroid cell tumor with bizarre nuclear atypia and CTNNB1 mutation.

Suzuki M, Matsushima J, Yazawa T, Ota S, Kiyokawa T, Sonehara H, Hanawa S, Mitsuhashi A, Shozu M, Nakatani Y.

Pathol Int. 2017 May;67(5):278-279. doi: 10.1111/pin.12524. Epub 2017 Mar 8. No abstract available.

PMID:
28271635
42.

Lack of partial renal response by 12 weeks after induction therapy predicts poor renal response and systemic damage accrual in lupus nephritis class III or IV.

Hanaoka H, Yamada H, Kiyokawa T, Iida H, Suzuki T, Yamasaki Y, Ooka S, Nagafuchi H, Okazaki T, Ichikawa D, Shirai S, Shibagaki Y, Koike J, Ozaki S.

Arthritis Res Ther. 2017 Jan 13;19(1):4. doi: 10.1186/s13075-016-1202-z.

43.

Preserving infrapyloric vein reduces postoperative gastric stasis after laparoscopic pylorus-preserving gastrectomy.

Kiyokawa T, Hiki N, Nunobe S, Honda M, Ohashi M, Sano T.

Langenbecks Arch Surg. 2017 Feb;402(1):49-56. doi: 10.1007/s00423-016-1529-6. Epub 2016 Nov 4.

PMID:
27815708
44.

Radical esophagectomy for a 92-year-old woman with granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma: a case report.

Kitani M, Yamagata Y, Tanabe A, Yagi K, Aikou S, Kiyokawa T, Nishida M, Yamashita H, Mori K, Nomura S, Seto Y.

World J Surg Oncol. 2016 Oct 13;14(1):264.

45.

Comparison Between Pathological Diagnosis and Cytogenetic Diagnosis by Short Tandem Repeat Polymorphism Analysis of Suspected Molar Pregnancies.

Usui H, Kiyokawa T, Qu J, Nishikimi K, Tate S, Mitsuhashi A, Nakatani Y, Shozu M.

J Reprod Med. 2016 May-Jun;61(5-6):219-23.

PMID:
27424362
46.

Physiological Evaluation of Childcare-Associated Muscle Load on the Neck and Shoulder Region in Japanese Women.

Yoshinaga S, Kiyokawa T, Kuramoto E, Kinoshita H, Nemoto S.

Nurs Res Pract. 2016;2016:1757094. doi: 10.1155/2016/1757094. Epub 2016 Mar 15.

47.

A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.

Carleton C, Hoang L, Sah S, Kiyokawa T, Karamurzin YS, Talia KL, Park KJ, McCluggage WG.

Am J Surg Pathol. 2016 May;40(5):636-44. doi: 10.1097/PAS.0000000000000578.

48.

Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer.

Mitsuhashi A, Sato Y, Kiyokawa T, Koshizaka M, Hanaoka H, Shozu M.

Ann Oncol. 2016 Feb;27(2):262-6. doi: 10.1093/annonc/mdv539. Epub 2015 Nov 16.

PMID:
26578736
49.

Gastric-type Endocervical Adenocarcinoma: An Aggressive Tumor With Unusual Metastatic Patterns and Poor Prognosis.

Karamurzin YS, Kiyokawa T, Parkash V, Jotwani AR, Patel P, Pike MC, Soslow RA, Park KJ.

Am J Surg Pathol. 2015 Nov;39(11):1449-57. doi: 10.1097/PAS.0000000000000532.

50.

Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.

Yamasaki Y, Satoh M, Mizushima M, Okazaki T, Nagafuchi H, Ooka S, Shibata T, Nakano H, Ogawa H, Azuma K, Maeda A, Tonooka K, Ito H, Takakuwa Y, Inoue M, Mitomi H, Kiyokawa T, Tsuchida K, Matsushita H, Mikage H, Murakami Y, Chan JY, Ozaki S, Yamada H.

Mod Rheumatol. 2016;26(3):403-9. doi: 10.3109/14397595.2015.1091155. Epub 2015 Oct 19.

PMID:
26344678

Supplemental Content

Loading ...
Support Center